Food & Function,
Год журнала:
2024,
Номер
15(8), С. 4475 - 4489
Опубликована: Янв. 1, 2024
The
fermented
yogurt
of
Lacticaseibacillus
rhamnosus
HF01
alters
obese
mice
gut
microbiota
by
boosting
beneficial
flora
and
butyric
acid,
activates
AMPK
to
regulate
lipid
metabolism,
combating
obesity.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2021,
Номер
11
Опубликована: Март 19, 2021
The
pathogenesis
of
type
2
diabetes
mellitus
(T2DM)
is
commonly
associated
with
altered
gut
bacteria.
However,
whether
the
microbial
dysbiosis
that
exists
in
human
diabetic
patients
or
without
retinopathy
different
remains
largely
unknown.
Here,
we
collected
clinical
information
and
fecal
samples
from
75
participants,
including
25
(DM),
(DR),
healthy
controls
(HC).
composition
three
groups
was
analyzed
using
16S
ribosomal
RNA
(rRNA)
gene
sequencing.
Microbial
structure
differed
groups.
α
β
diversities
both
DM
DR
were
reduced
compared
those
HC
group.
Blautia
most
abundant
genus,
especially
In
addition,
increased
levels
Bifidobacterium
Lactobacillus
decreased
Escherichia-Shigella,
Faecalibacterium
,
Eubacterium_hallii_group
Clostridium
genera
observed
Furthermore,
a
biomarker
set
bacterial
families,
which
could
distinguish
group
identified,
area
under
curve
values
ranging
0.69
to
0.85.
Of
note,
Pasteurellaceae
HC,
generated
high
AUC
(0.74)
as
an
individual
predictive
biomarker.
Moreover,
14
family
biomarkers
fasting
blood
glucose
diabetes,
them
being
negatively
correlated.
summary,
our
study
establishes
compositional
alterations
microbiota
DR,
suggesting
potential
use
non-invasive
for
differential
diagnosis,
well
identifying
therapeutic
targets
retinopathy.
Frontiers in Nutrition,
Год журнала:
2021,
Номер
8
Опубликована: Май 19, 2021
Increasing
studies
have
shown
that
obesity
is
the
primary
cause
of
cardiovascular
diseases,
non-alcoholic
fatty
liver
type
2
diabetes,
and
a
variety
cancers.
The
dysfunction
gut
microbiota
was
proved
to
result
in
obesity.
Recent
research
indicated
ANGPTL4
key
regulator
lipid
metabolism
circulating
medium
for
fat
deposition.
present
study
conducted
investigate
alteration
expression
gastrointestinal
tract
mice
treated
by
high-fat
diet.
Ten
C57BL/6J
were
randomly
allocated
two
groups
fed
with
diet
(HFD)
containing
60%
or
normal-fat
(Control)
10%
fat.
segments
ileum
colon
collected
determination
RT-qPCR
immunohistochemical
analysis
while
ileal
colonic
contents
16S
rRNA
gene
sequencing.
results
showed
HFD
significantly
increased
body
weight,
epididymal
perirenal
content
(
P
<
0.05).
relative
ANGPTL4-positive
cells
treatment.
Furthermore,
sequencing
suggested
treatment
changed
composition
microbiota.
ratio
Firmicutes
Bacteroidetes
abundance
Allobaculum
higher
group
than
Control
Adlercreutzia,
Bifidobacterium,
Prevotellaceae
UCG-001
,
Ruminococcus
decreased.
Interestingly,
positively
correlated
ANGPTL4.
These
findings
provide
theoretical
foundation
development
strategies
control
related
diseases
regulation
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(4), С. 3817 - 3817
Опубликована: Фев. 14, 2023
Inflammatory
bowel
disease
(IBD)
is
an
inflammatory
of
the
gastrointestinal
tract,
incidence
which
has
rapidly
increased
worldwide,
especially
in
developing
and
Western
countries.
Recent
research
suggested
that
genetic
factors,
environment,
microbiota,
immune
responses
are
involved
pathogenesis;
however,
underlying
causes
IBD
unclear.
Recently,
gut
microbiota
dysbiosis,
a
decrease
abundance
diversity
specific
genera,
been
as
trigger
for
IBD-initiating
events.
Improving
identifying
bacterial
species
essential
understanding
pathogenesis
treatment
autoimmune
diseases.
Here,
we
review
different
aspects
role
played
by
provide
theoretical
basis
modulating
through
probiotics,
fecal
transplantation,
microbial
metabolites.
Microorganisms,
Год журнала:
2022,
Номер
10(2), С. 452 - 452
Опубликована: Фев. 16, 2022
Obesity,
a
worldwide
health
concern
with
constantly
rising
prevalence,
is
multifactorial
chronic
disease
associated
wide
range
of
physiological
disruptions,
including
energy
imbalance,
central
appetite
and
food
reward
dysregulation,
hormonal
alterations
gut
dysbiosis.
The
microbiome
well-recognized
factor
in
the
pathophysiology
obesity,
its
influence
on
host
physiology
has
been
extensively
investigated
over
last
decade.
This
review
highlights
mechanisms
by
which
dysbiosis
can
contribute
to
obesity.
In
particular,
we
discuss
microbiota's
contribution
homeostatic
changes,
low-grade
inflammation,
regulation
fat
deposition
bile
acid
metabolism
via
bacterial
metabolites,
such
as
short-chain
fatty
acids,
components,
lipopolysaccharides,
among
others.
Finally,
therapeutic
strategies
based
next-generation
probiotics
aiming
re-shape
intestinal
microbiota
reverse
metabolic
obesity
are
described.
World Psychiatry,
Год журнала:
2023,
Номер
22(3), С. 366 - 387
Опубликована: Сен. 15, 2023
Populations
with
common
physical
diseases
–
such
as
cardiovascular
diseases,
cancer
and
neurodegenerative
disorders
experience
substantially
higher
rates
of
major
depressive
disorder
(MDD)
than
the
general
population.
On
other
hand,
people
living
MDD
have
a
greater
risk
for
many
diseases.
This
high
level
comorbidity
is
associated
worse
outcomes,
reduced
adherence
to
treatment,
increased
mortality,
health
care
utilization
costs.
Comorbidity
can
also
result
in
range
clinical
challenges,
more
complicated
therapeutic
alliance,
issues
pertaining
adaptive
behaviors,
drug‐drug
interactions
adverse
events
induced
by
medications
used
mental
disorders.
Potential
explanations
prevalence
above
involve
shared
genetic
biological
pathways.
These
latter
include
inflammation,
gut
microbiome,
mitochondrial
function
energy
metabolism,
hypothalamic‐pituitary‐adrenal
axis
dysregulation,
brain
structure
function.
Furthermore,
several
antecedents
related
social
factors
(e.g.,
socioeconomic
status),
lifestyle
variables
activity,
diet,
sleep),
stressful
live
childhood
trauma).
Pharmacotherapies
psychotherapies
are
effective
treatments
comorbid
MDD,
introduction
interventions
well
collaborative
models
digital
technologies
provide
promising
strategies
improving
management.
paper
aims
detailed
overview
epidemiology
specific
including
bidirectional
risk;
pathways
potentially
implicated
pathogenesis
diseases;
socio‐environmental
that
serve
both
protective
factors;
management
prevention
treatment.
We
conclude
future
directions
emerging
research
optimal
Despite
a
short
history
since
its
first
isolation,
Akkermansia
muciniphila
has
been
extensively
studied
in
relation
to
effects
on
human
metabolism.
A
recent
intervention
study
also
demonstrated
that
the
bacterium
is
safe
use
for
therapeutic
purposes.
The
best-known
of
A.
health
and
disease
relate
ability
strengthen
gut
integrity,
modulate
insulin
resistance,
protect
host
from
metabolic
inflammation.
further
molecular
mechanism,
induction
GLP-1
secretion
through
ICAM-2
receptor,
was
recently
discovered
with
identification
new
bacterial
protein
produced
by
muciniphila.
However,
other
studies
have
suggested
detrimental
role
specific
immune
settings.
Here,
we
evaluate
molecular,
mechanistic
suggest
some
missing
links
be
connected
before
organism
should
considered
as
next-generation
biotherapeutic
agent.